Latest Breaking News On - Nichol ochsner - Page 4 : comparemela.com

Zevra Therapeutics Appoints Neil F McFarlane as President, Chief Executive Officer and Director

Zevra Therapeutics Appoints Neil F McFarlane as President, Chief Executive Officer and Director
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesChristalmm mickleNichol ochsnerJoe saluriJanine bogrisTamaraa seymour favoritoNeilf mcfarlaneJosephb saluriChristal mickleRetrophin incUniversity of floridaTravere therapeutics incCompensation committee of zevra board directorsDevelopment officerUnited states armySangstat medical corporation

Zevra Therapeutics Announces Interim Data from the Phase 2 Clinical Trial of KP1077 for Idiopathic Hypersomnia

Zevra Therapeutics Announces Interim Data from the Phase 2 Clinical Trial of KP1077 for Idiopathic Hypersomnia
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesNichol ochsnerJanine bogrisRene braeckmanUs drug enforcement agencyClinical developmentExchange commissionZevra therapeutics incDrug administrationSenior vice presidentEpworth sleepiness scalePatient global impressionClinical global impressionIdiopathic hypersomnia severity scaleIdiopathic hypersomniaOrphan drug designation

Zevra Therapeutics to Participate in the Cantor Global

CELEBRATION, Fla., Sept. 20, 2023 (GLOBE NEWSWIRE) Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a rare disease therapeutics.

Janine bogrisNichol ochsnerExchange commissionZevra therapeutics incCantor global healthcare conferenceInvestor relationsZevra therapeuticsConcerning forward looking statementsPrivate securities litigation reform actAnnual reportQuarterly reportNasdaq zvraZevra therapeutics

Zevra Therapeutics to Participate in the Cantor Global Healthcare Conference - Zevra Therapeutics (NASDAQ:ZVRA)

CELEBRATION, Fla., Sept. 20, 2023 (GLOBE NEWSWIRE) Zevra Therapeutics, Inc. (NASDAQ:ZVRA) (Zevra, or the Company), a rare disease therapeutics company, today announced that executive management will participate in a

Janine bogrisNichol ochsnerExchange commissionZevra therapeutics incCantor global healthcare conferenceInvestor relationsZevra therapeuticsConcerning forward looking statementsPrivate securities litigation reform actAnnual reportQuarterly report

Zevra Therapeutics Presents Full Data Set on the

CELEBRATION, Fla., Sept. 09, 2023 (GLOBE NEWSWIRE) Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a rare disease therapeutics.

United statesJennifer arcureRene braeckmanNichol ochsnerPsych congress poster award reception onUs drug enforcement agencyCorium incClinical development at zevraPsych congressZevra therapeutics incClinical developmentDrug administrationExchange commissionVice presidentPsych congress poster award receptionSingle dose crossover study